What is Spravato (esketamine): What You Need to Know
In a significant development for mental health treatment, the United States Food and Drug Administration (FDA) has approved Johnson & Johnson’s Spravato (esketamine) nasal spray for stand-alone use in adults with treatment-resistant major depressive disorder (MDD). This marks a major milestone, making Spravato the first therapy of its kind approved for use without a concurrent … Read more